Investigating the role of bioactive sphingolipids in Friedreich’s ataxia (FRDA)
Funder: Ataxia UKDuration: January 2021 - July 2021
Project Grant
People
| Name | Telephone | Office | ||
|---|---|---|---|---|
|
Dr Sara Anjomani Virmouni Senior Lecturer in Biomedical Sciences (Principal investigator)
T: +44 (0)1895 268165
E: sara.anjomanivirmouni@brunel.ac.uk |
+44 (0)1895 268165 | sara.anjomanivirmouni@brunel.ac.uk |
Outputs
Kwa, F., Anjomani Virmouni, S., Ramchunder, Z., Kendal, E. and Xiao, J. (2026) 'Deciphering the Missing Links between Friedreich Ataxia and Multiple Sclerosis for Targeted Drug Development'. Drug Discovery Today, 0 (accepted, in press). ISSN: 1359-6446 Open Access Link
Edzeamey, FJ., Ramchunder, Z., McCarthy, RR. and Anjomani-Virmouni, S. (2025) 'Galleria mellonella as a drug discovery model to study oxidative stress'. Scientific Reports, 15 (1). pp. 1 - 10. ISSN: 2045-2322 Open Access Link